Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

1,860.00p
   
  • Change Today:
    -8.00p
  • 52 Week High: 2,568.00
  • 52 Week Low: 1,637.00
  • Currency: UK Pounds
  • Shares Issued: 66.03m
  • Volume: 829,710
  • Market Cap: £1,228.21m
  • RiskGrade: 128

US court rules on damages for Genus technology infringements

By Frank Prenesti

Date: Wednesday 11 Sep 2019

LONDON (ShareCast) - (Sharecast News) - Genus on Wednesday said a US court had ruled on damages over infringement of two bull semen sexing patents sold by ABS Global under the Intelligen brand.
A District Court jury in Wisconsin said ABS should pay a royalty of $2.60 per straw sold for the infringement of the patents, known as 476 and 309, for 3.3m straws sold up to 30 June 2019.

The damages will be retrospective only as ABS has now modified the technology to avoid continued infringement.

On Tuesday, the jury held that the IntelliGen technology infringed three other patents, which confirmed ABS' existing obligation to pay a royalty of $1.25 for each straw of sexed semen produced in the US, the company said.

ABS is considering its options for appeal, Genus said.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Genus Market Data

Currency UK Pounds
Share Price 1,860.00p
Change Today -8.00p
% Change -0.43 %
52 Week High 2,568.00
52 Week Low 1,637.00
Volume 829,710
Shares Issued 66.03m
Market Cap £1,228.21m
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average96.04% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
56.88% below the market average56.88% below the market average56.88% below the market average56.88% below the market average56.88% below the market average
7.41% above the sector average7.41% above the sector average7.41% above the sector average7.41% above the sector average7.41% above the sector average
Income
86.38% below the market average86.38% below the market average86.38% below the market average86.38% below the market average86.38% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average67.9% below the market average
64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average64.71% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 0
Sell 0
Strong Sell 0
Total 7
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 29-Feb-24 09-Nov-23
Paid 28-Mar-24 08-Dec-23
Amount 10.30p 21.70p

Trades for 14-May-2024

Time Volume / Share Price
16:35 26,212 @ 1,860.00p
16:35 52 @ 1,860.00p
16:35 364 @ 1,860.00p
16:35 364 @ 1,860.00p
16:35 62 @ 1,860.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page